A paradigm shift in immunotherapy. Targeting the Human Endogenous Retroviruses to Treat Cancer
The design of the HERV immunogen to treat cancer
Know more of this patent
Under evaluation at least till: 12th of April 2022
Better Care Better Care provides medical device integration...
Goliver Therapeutics Goliver Therapeutics treats severe acu...
LabSafe Metrics LabSafe Metrics uses AI to predict drug rel...